Literature DB >> 19890424

Glucose self-monitoring: an end in itself or the Holy Grail?

Jochen Seufert.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19890424      PMCID: PMC2770222          DOI: 10.3238/arztebl.2009.0585

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  7 in total

1.  Self monitoring of blood glucose in type 2 diabetes.

Authors:  Martin Gulliford
Journal:  BMJ       Date:  2008-04-17

2.  Self monitoring of glucose by people with diabetes. Self monitoring improves quality of life and prognosis of people with diabetes.

Authors:  M de Alva; J Jervell
Journal:  BMJ       Date:  1997-07-19

3.  Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Diabetes       Date:  1997-02       Impact factor: 9.461

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

5.  Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.

Authors:  Maurice J O'Kane; Brendan Bunting; Margaret Copeland; Vivien E Coates
Journal:  BMJ       Date:  2008-04-17

Review 6.  Self-monitoring of blood glucose in diabetes mellitus: arguments for an individualized approach.

Authors:  Michael A Nauck; Andrea El-Ouaghlidi; Irfan Vardarli
Journal:  Dtsch Arztebl Int       Date:  2009-09-11       Impact factor: 5.594

7.  Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Authors:  A J Farmer; A N Wade; D P French; J Simon; P Yudkin; A Gray; A Craven; L Goyder; R R Holman; D Mant; A-L Kinmonth; H A W Neil
Journal:  Health Technol Assess       Date:  2009-02       Impact factor: 4.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.